G). 2008;16:146?2. 4. Boulet LP, Franssen E. Impact of weight problems on reaction to

G). 2008;16:146?2. 4. Boulet LP, Franssen E. Impact of being overweight on reaction to fluticasone with or with no salmeterol in moderate bronchial asthma. Respir Med. 2007;one zero one:2240?. 5. Peters-Golden M, Swern A, Chicken SS, Hustad CM, Grant E, Edelman JM. Affect of overall body mass index to the reaction to bronchial asthma controller agents. Eur Respir J. 2006;27:495?03. six. Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. System mass and glucocorticoid reaction in asthma. Am J Respir Crit Care Med. 2008;178:682?. seven. Holguin F, Comhair SA, Hazen SL, Powers RW, Khatri SS, Bleecker ER, et al. An affiliation in between L-arginine/asymmetric dimethyl arginine balance, being overweight, as well as age of asthma onset phenotype. Am J Respir Crit Care Med. 2013;187:153?. eight. Holguin F, Fitzpatrick A. Obesity, asthma, and oxidative stress. J Appl Physiol (1985). 2010;108:754?. 9. Al-Alwan A, Bates JH, Chapman DG, Kaminsky DA, DeSarno MJ, Irvin CG, et al. The nonallergic asthma of weight problems. A make any difference of distal lung compliance. Am J Respir Crit Care Med. 2014;189:1494?02. 10. Sood A, Shore SA. Adiponectin, leptin, and resistin in bronchial asthma: fundamental mechanisms via inhabitants scientific tests. J Allergy (Cairo). 2013;2013:785835.eleven. Sideleva O, Suratt BT, Black KE, Tharp WG, Pratley RE, Forgione P, et al. Weight problems and bronchial asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med. 2012;186:598?05. 12. Belfort R, Merestinib Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al. A placebo-controlled demo of pioglitazone in topics with nonalcoholic PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/27908723 steatohepatitis. N Engl J Med. 2006;355:2297?07. 13. Benayoun L, Letuve S, Druilhe A, Boczkowski J, Dombret MC, Mechighel P, et al. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am J Respir Crit Care Med. 2001;164:1487?four. 14. Hammad H, de Heer HJ, Soullie T, Angeli V, Trottein F, Hoogsteden HC, et al. Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the event of eosinophilic airway inflammation inside of a mouse design of asthma. Am J Pathol. 2004;164:263?one. fifteen. Lee KS, Kim SR, Park SJ, Park HS, Min KH, Jin SM, et al. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible issue 1alpha in allergic airway ailment of mice. J Allergy Clin Immunol. 2006;118:one hundred twenty?. sixteen. Honda K, Marquillies P, Capron M, Dombrowicz D. Peroxisome proliferatoractivated receptor gamma is expressed in airways and inhibits options of airway reworking inside of a mouse asthma model. J Allergy Clin Immunol. 2004;113:882?. seventeen. Woerly G, Honda K, Loyens M, Papin JP, Auwerx J, Staels B, et al. Peroxisome proliferator-activated receptors alpha and gamma downregulate allergic swelling and eosinophil activation. J Exp Med. 2003;198:411?1. 18. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Growth and validation of a questionnaire to measure asthma manage. Eur Respir J. 1999;14:902?. 19. Narala VR, Ranga R, Smith MR, Berlin AA, Standiford TJ, Lukacs NW, et al. Pioglitazone is as productive as dexamethasone within a cockroach allergeninduced murine design of bronchial asthma. Respir Res. 2007;8:ninety. twenty. Belvisi MG, Mitchell JA. Targeting PPAR receptors while in the PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28495082 airway for the procedure of inflammatory lung ailment. Br J Pharmacol. 2009;158:994?003. 21. Richards DB, Bareille P, Lindo EL, Quinn D, Farrow SN. Remedy using a.